A 25-year-old female with asthma reports increased wheezing during exercise. Which of the following interventions is most appropriate to manage her symptoms before physical activity?

A) Use her albuterol inhaler 15 minutes before exercise

B) Avoid all physical activity to prevent wheezing

C) Increase fluid intake before exercise

D) Wear a mask during exercise to filter out allergens

What is the primary purpose of conducting a spirometry test for a patient with asthma?

B) To evaluate the patient's lung function and airflow obstruction

A) To measure the patient's heart rate during physical exertion

B) To evaluate the patient's lung function and airflow obstruction

C) To determine the presence of specific allergens causing asthma

D) To assess the patient's oxygen saturation levels continuously

Which of the following medications is commonly used as a maintenance therapy to reduce airway inflammation in asthma patients?

A) Inhaled corticosteroid (ICS)

What is the primary purpose of prescribing a low-dose inhaled corticosteroid (ICS) for a patient with asthma?

B) To reduce airway inflammation and prevent exacerbations

A) To provide immediate relief of acute asthma symptoms

B) To reduce airway inflammation and prevent exacerbations

C) To increase the patient's heart rate during exercise

D) To replace the need for a rescue inhaler entirely

Which of the following is the primary purpose of the patient's use of an inhaled corticosteroid (ICS) in asthma management?

B) To act as a preventative measure by reducing inflammation in the airways

A) To provide immediate relief of acute asthma symptoms

B) To act as a preventative measure by reducing inflammation in the airways

C) To increase the strength of respiratory muscles

D) To treat infections in the respiratory tract

Which of the following statements is true regarding the use of inhaled corticosteroids (ICS) in asthma management?

B) ICS are effective in reducing inflammation in the airways.

A) ICS should only be used during asthma exacerbations.

B) ICS are effective in reducing inflammation in the airways.

C) ICS can be used interchangeably with rescue inhalers like albuterol.

D) ICS are primarily used to treat acute bronchospasm.

What is the primary reason for advising the patient to use her inhaled corticosteroid (ICS) consistently?

C) To maintain long-term control of asthma and prevent flare-ups

A) To reduce the need for her albuterol inhaler

B) To prevent exercise-induced asthma symptoms

C) To maintain long-term control of asthma and prevent flare-ups

D) To improve her Peak Expiratory Flow Rate (PEFR) immediately

What is the primary purpose of using an inhaled corticosteroid (ICS) in asthma management?

B) To reduce inflammation and prevent asthma exacerbations

A) To provide immediate relief of asthma symptoms

B) To reduce inflammation and prevent asthma exacerbations

C) To increase oxygen saturation levels during an asthma attack

D) To replace the need for a rescue inhaler during exercise

Which of the following is a primary benefit of the patient's consistent use of inhaled corticosteroids (ICS) in asthma management?

B) Prevention of asthma exacerbations

A) Reduction of systemic side effects

B) Prevention of asthma exacerbations

C) Immediate relief of acute symptoms

D) Elimination of the need for rescue inhalers

Which of the following is the most appropriate action by the nurse to promote continued asthma management for this patient?

B) Reinforce the importance of adherence to the inhaled corticosteroid regimen

A) Encourage the patient to stop using the inhaled corticosteroid if symptoms improve

B) Reinforce the importance of adherence to the inhaled corticosteroid regimen

C) Advise the patient to use the inhaled corticosteroid only during asthma exacerbations

D) Suggest the patient reduce the frequency of peak flow monitoring

asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: Inflammation of the airways caused by immune system overreaction to triggers (like allergens or irritants) leads to swelling and mucus production, narrowing the airways and making it difficult to breathe.

• Secondary mechanism: Bronchoconstriction, where the muscles around the airways tighten in response to triggers, further reducing airflow and causing wheezing and shortness of breath.

• Key complication: Repeated asthma attacks can lead to airway remodeling, a minor complication where structural changes in the airway walls occur, potentially increasing chronic symptoms and reducing lung function over time.

Patient Profile

Demographics:

25-year-old female, office assistant

History:

• Key past medical history: Diagnosed with mild intermittent asthma 2 years ago

• Current medications: As-needed albuterol inhaler

• Allergies: None known

Current Presentation:

• Chief complaint: Occasional shortness of breath

• Key symptoms: Wheezing and mild shortness of breath during exercise

• Vital signs: Blood pressure 118/76 mmHg, heart rate 72 bpm, respiratory rate 16 breaths per minute, temperature 98.6°F, oxygen saturation 98% on room air

Section 1

Initial Assessment Findings:

Upon her visit to the clinic, the 25-year-old female office assistant is observed to be in no acute distress. A focused respiratory assessment reveals mild wheezing upon auscultation of the lung fields, predominantly during expiration, with the wheezing more pronounced in the upper lobes. Her respiratory effort appears unlabored at rest, and she is able to speak in full sentences without difficulty. Her overall respiratory rate remains at 16 breaths per minute, which is within normal limits, and her oxygen saturation remains at 98% on room air, indicating effective oxygenation.

In reviewing her lifestyle and potential triggers, she reports that her symptoms are primarily precipitated by physical exertion, such as climbing stairs or engaging in aerobic exercise. She also notes that exposure to dust at her workplace occasionally exacerbates her symptoms, though she has not identified any specific allergens that trigger her asthma. Her current management with an as-needed albuterol inhaler appears to provide relief during episodes of shortness of breath. However, the frequency of these episodes, particularly during exercise, has slightly increased over the past few months, suggesting a need for reassessment of her asthma management plan.

The healthcare team decides to conduct a spirometry test to evaluate her lung function more comprehensively. The results of this test will help determine if there are any changes in her pulmonary function that require adjustments in her treatment strategy. In the meantime, patient education focuses on avoiding known triggers, proper inhaler technique, and monitoring for any changes in her symptoms. This assessment sets the stage for evaluating her current treatment efficacy and considering potential modifications to her asthma management plan.

Section 2

Following the initial assessment, the patient undergoes spirometry testing to gain further insight into her lung function. The spirometry results show a mild reduction in her Forced Expiratory Volume in one second (FEV1), which measures at 78% of the predicted value. The FEV1/FVC (Forced Vital Capacity) ratio is slightly decreased, indicating the presence of an obstructive pattern consistent with asthma. These findings suggest that while her asthma is in the early stages, there is a need to address her exercise-induced symptoms more effectively.

The healthcare team discusses these results with the patient, explaining the importance of optimizing her asthma management to prevent exacerbations and maintain her quality of life. As a result, they decide to initiate a low-dose inhaled corticosteroid (ICS) as a maintenance therapy to reduce airway inflammation and potentially decrease her reliance on the albuterol inhaler. The patient is instructed on the proper use of the ICS inhaler and the importance of adherence to the prescribed regimen.

In addition, the patient receives education on lifestyle modifications to help manage her asthma. She is advised to monitor her symptoms closely, particularly during exercise, and to consider using her albuterol inhaler 15 minutes before engaging in physical activity as a preventive measure. The healthcare team emphasizes the importance of avoiding dust exposure as much as possible and implementing dust-mitigation strategies in her workplace. A follow-up appointment is scheduled in four weeks to reassess her symptoms, review her inhaler technique, and evaluate the effectiveness of the new treatment plan. This approach aims to empower the patient with knowledge and tools to manage her asthma effectively and prevent future complications.

Section 3

Four weeks later, the patient returns for her follow-up appointment. During the initial assessment, she reports a noticeable improvement in her symptoms, particularly during exercise. She mentions that by using her albuterol inhaler 15 minutes before physical activity, she has been able to complete her workouts with less difficulty and no episodes of wheezing or shortness of breath. However, she admits that she occasionally forgets to take her inhaled corticosteroid (ICS) once or twice a week, especially on weekends. Despite this, she feels her overall control of asthma has improved.

The healthcare team conducts a thorough assessment, noting that her vital signs are stable: respiratory rate is 16 breaths per minute, heart rate is 78 beats per minute, and oxygen saturation is 98% on room air. During the physical examination, the patient's lung sounds are clear bilaterally with no wheezing detected, and she appears to be in good general health. Her Peak Expiratory Flow Rate (PEFR) has increased to 85% of her personal best, indicating better airflow and control since the last visit. These findings suggest that the addition of the ICS, along with lifestyle modifications, has positively impacted her asthma management.

The team takes this opportunity to reiterate the importance of adherence to the ICS regimen to maintain these improvements and prevent future exacerbations. They provide tips for remembering to take the medication daily, such as setting reminders on her phone or associating it with another routine activity. To further support her management plan, they discuss potential environmental triggers and review strategies for minimizing dust exposure, both at home and in her workplace. The patient expresses gratitude for the support and education she has received, and a follow-up appointment is scheduled for three months to continue monitoring her progress and adjust her treatment plan as needed.

Section 4

Three months later, the patient returns for her scheduled follow-up appointment. During the initial assessment, she reports feeling well overall but admits to experiencing mild symptoms of wheezing and chest tightness over the past week, particularly in the evenings. She has been diligent in using her albuterol inhaler before exercise, which continues to prevent symptoms during physical activity. However, she acknowledges missing her inhaled corticosteroid (ICS) dose on several occasions due to a busy work schedule and recent travel. Despite these lapses, she feels her asthma is generally under control.

The healthcare team conducts a comprehensive assessment and finds that her vital signs remain stable: her respiratory rate is 18 breaths per minute, heart rate is 80 beats per minute, and oxygen saturation is 97% on room air. During the physical examination, her lung sounds are clear, but a faint wheeze is noted on forced expiration. Her Peak Expiratory Flow Rate (PEFR) has slightly decreased to 80% of her personal best. These findings suggest a mild decline in asthma control, likely due to inconsistent adherence to her ICS regimen.

In response to these findings, the team reiterates the importance of consistent ICS use to prevent symptom flare-ups and maintain optimal lung function. They discuss strategies to improve adherence, including the use of a weekly pill organizer that can be placed next to her toothbrush, ensuring she remembers her evening dose. The patient is encouraged to continue identifying and avoiding potential asthma triggers, particularly during travel. A follow-up appointment is scheduled for six weeks to reassess her asthma control and evaluate the effectiveness of the adjusted management plan. The team emphasizes open communication, urging her to reach out if symptoms worsen or if she encounters any challenges with her treatment regimen.

Section 5

At the six-week follow-up appointment, the patient reports that she has been more consistent with her inhaled corticosteroid regimen, thanks to the reminder tool suggested by the healthcare team. She has not missed a dose in the past month and has noticed an improvement in her evening symptoms. She describes her wheezing and chest tightness as significantly reduced, with only occasional mild episodes. Her adherence to the medication plan and avoidance of known triggers has positively impacted her asthma control.

During the physical assessment, her vital signs remain stable with a respiratory rate of 16 breaths per minute, heart rate of 76 beats per minute, and oxygen saturation at 98% on room air. Lung auscultation reveals clear breath sounds with no wheezing on forced expiration. Her Peak Expiratory Flow Rate (PEFR) has improved to 90% of her personal best, indicating better airflow and control of her asthma symptoms. These findings suggest that the consistent use of her ICS has effectively managed her asthma, preventing further decline and reducing symptom frequency.

The healthcare team praises the patient for her adherence and proactive approach to managing her asthma. They encourage her to maintain her current routine and reinforce the importance of continuing the ICS to prevent future exacerbations. A future follow-up is scheduled in three months to ensure sustained asthma control and to make any necessary adjustments to her management plan. The patient expresses confidence in managing her condition and a willingness to reach out if any changes or concerns arise.